- Conditions
- Acute Burns
- Interventions
- Magellan®, Placebo Saline Gel and Usual and Customary Standard of Care
- Device · Other
- Lead sponsor
- Arteriocyte, Inc.
- Industry
- Eligibility
- 18 Years to 86 Years
- Enrollment
- 42 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2018
- U.S. locations
- 3
- States / cities
- Sacramento, California • Washington D.C., District of Columbia • Salt Lake City, Utah
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–4
of 4
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Burn, 2nd Degree Burn of the Skin, 3rd Degree Burn of the Skin, 1st Degree Burn of the Skin
- Interventions
- 3D Imaging
- Device
- Lead sponsor
- HealthPartners Institute
- Other
- Eligibility
- 18 Years to 89 Years
- Enrollment
- 8 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Saint Paul, Minnesota
- Conditions
- Third Degree Burn, Burns, Wound Infection, Degloving Injury
- Interventions
- StrataGraft Skin Tissue, Cadaver allograft
- Biological · Procedure
- Lead sponsor
- Stratatech, a Mallinckrodt Company
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2008
- U.S. locations
- 2
- States / cities
- Phoenix, Arizona • Madison, Wisconsin
- Conditions
- Burns Degree Third, Burn (Disorder), Burn Degree Second, Thermal Burn, Wound Heal
- Interventions
- Skin Xenotransplant, Autograft(ing)
- Drug · Procedure
- Lead sponsor
- XenoTherapeutics, Inc.
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2026
- U.S. locations
- 4
- States / cities
- Phoenix, Arizona • Augusta, Georgia • Portland, Maine + 1 more